ASND vs. CRVS

Last updated Jun 9, 2026

ASND (Ascendis Pharma A/S) and CRVS (Corvus Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ASND returned 31.35%/yr vs -1.39%/yr for CRVS. At a 0.23 correlation, their price movements are largely independent.

Performance

ASND vs. CRVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ascendis Pharma A/S (ASND) and Corvus Pharmaceuticals, Inc. (CRVS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ASND achieves a -3.48% return, which is significantly lower than CRVS's 44.81% return. Over the past 10 years, ASND has outperformed CRVS with an annualized return of 31.35%, while CRVS has yielded a comparatively lower -1.39% annualized return.

ASND

• 1D: -2.20%
• 1M: -13.76%
• YTD: -3.48%
• 6M: -0.63%
• 1Y: 18.92%
• 3Y*: 30.47%
• 5Y*: 9.47%
• 10Y*: 31.35%

CRVS

• 1D: 0.27%
• 1M: -28.30%
• YTD: 44.81%
• 6M: 30.26%
• 1Y: 185.17%
• 3Y*: 46.04%
• 5Y*: 31.93%
• 10Y*: -1.39%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ASND vs. CRVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ASND Ascendis Pharma A/S	-3.48%	54.89%	9.31%	3.13%	-9.22%	-19.34%	19.88%	122.06%	56.39%	97.92%
CRVS Corvus Pharmaceuticals, Inc.	44.81%	43.93%	203.98%	107.06%	-64.73%	-32.30%	-34.56%	48.23%	-64.58%	-27.55%

Correlation

The correlation between ASND and CRVS is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.24
Correlation (3Y) Calculated over the trailing 3-year period	0.20
Correlation (5Y) Calculated over the trailing 5-year period	0.26
Correlation (10Y) Calculated over the trailing 10-year period	0.23
Correlation (All Time) Calculated using the full available price history since Mar 24, 2016	0.23

Fundamentals

Market Cap ASND : $13.28B CRVS : $1.00B
EPS ASND : $8.08 CRVS : -$0.53
PB Ratio ASND : 27.18 CRVS : 4.17
Total Revenue (TTM) ASND : $867.51M CRVS : $0.00
Gross Profit (TTM) ASND : $764.89M CRVS : -$26.00K
EBITDA (TTM) ASND : -$6.94M CRVS : -$47.43M

Return for Risk

ASND vs. CRVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASND

ASND Risk / Return Rank: 60
ASND Sharpe Ratio Rank: 60
ASND Sortino Ratio Rank: 55
ASND Omega Ratio Rank: 53
ASND Calmar Ratio Rank: 65
ASND Martin Ratio Rank: 70

CRVS

CRVS Risk / Return Rank: 86
CRVS Sharpe Ratio Rank: 74
CRVS Sortino Ratio Rank: 96
CRVS Omega Ratio Rank: 93
CRVS Calmar Ratio Rank: 85
CRVS Martin Ratio Rank: 83

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASND vs. CRVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ascendis Pharma A/S (ASND) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ASND	CRVS	Difference
Sharpe ratio: Return per unit of total volatility	0.52	1.03	-0.51
Sortino ratio: Return per unit of downside risk	0.99	4.25	-3.26
Omega ratio: Gain probability vs. loss probability	1.12	1.48	-0.36
Calmar ratio: Return relative to maximum drawdown	1.09	3.30	-2.21
Martin ratio: Return relative to average drawdown	3.52	7.42	-3.90
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ASND vs. CRVS - Sharpe Ratio Comparison

The current ASND Sharpe Ratio is 0.52, which is lower than the CRVS Sharpe Ratio of 1.03. The chart below compares the historical Sharpe Ratios of ASND and CRVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ASND	CRVS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.52	1.03	-0.51
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.20	0.24	-0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.62	-0.01	+0.63
Sharpe Ratio (All Time) Calculated using the full available price history	0.46	-0.02	+0.49

Drawdowns

ASND vs. CRVS - Drawdown Comparison

The maximum ASND drawdown since its inception was -61.72%, smaller than the maximum CRVS drawdown of -96.97%. Use the drawdown chart below to compare losses from any high point for ASND and CRVS.

Drawdown Indicators

	ASND	CRVS	Difference
Max Drawdown Largest peak-to-trough decline	-61.72%	-96.97%	+35.25%
Max Drawdown (1Y) Largest decline over 1 year	-17.62%	-56.43%	+38.81%
Max Drawdown (3Y) Largest decline over 3 years	-29.15%	-70.50%	+41.35%
Max Drawdown (5Y) Largest decline over 5 years	-60.46%	-92.40%	+31.94%
Max Drawdown (10Y) Largest decline over 10 years	-61.72%	-96.97%	+35.25%
Current Drawdown Current decline from peak	-17.62%	-56.31%	+38.69%
Average Drawdown Average peak-to-trough decline	-18.71%	-69.32%	+50.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.45%	25.07%	-19.62%

Volatility

ASND vs. CRVS - Volatility Comparison

The current volatility for Ascendis Pharma A/S (ASND) is 14.11%, while Corvus Pharmaceuticals, Inc. (CRVS) has a volatility of 23.70%. This indicates that ASND experiences smaller price fluctuations and is considered to be less risky than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ASND	CRVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.11%	23.70%	-9.59%
Volatility (6M) Calculated over the trailing 6-month period	29.67%	111.87%	-82.20%
Volatility (1Y) Calculated over the trailing 1-year period	37.02%	181.10%	-144.08%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	48.63%	131.06%	-82.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	51.11%	111.16%	-60.05%

Dividends

ASND vs. CRVS - Dividend Comparison

Neither ASND nor CRVS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ASND and CRVS in my portfolio?

ASND and CRVS have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ASND or CRVS?

CRVS has higher volatility (23.70%) compared to ASND (14.11%). In terms of maximum drawdown, ASND dropped -61.72% vs CRVS's -96.97%.

Which has better risk-adjusted returns?

CRVS currently has the higher Sharpe Ratio (1.03 vs 0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.